Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001866833 | SCV002119730 | uncertain significance | not provided | 2022-10-17 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available"). ClinVar contains an entry for this variant (Variation ID: 1355272). This missense change has been observed in individual(s) with clinical features of Rothmund-Thomson syndrome (PMID: 32369273). This variant is present in population databases (rs769630452, gnomAD 0.03%). This sequence change replaces glycine with serine at codon 34 of the USB1 protein (p.Gly34Ser). The glycine residue is weakly conserved and there is a small physicochemical difference between glycine and serine. |
Mayo Clinic Laboratories, |
RCV001866833 | SCV002541328 | uncertain significance | not provided | 2021-04-07 | criteria provided, single submitter | clinical testing |